• Sutro Biopharma (NASDAQ:STRO) Lowered to "Underperform" Rating by Bank of America

    Source: Buzz FX / 15 Mar 2025 08:16:17   America/New_York


    Sutro Biopharma (NASDAQ:STRO) Lowered to "Underperform" Rating by Bank of America Written by MarketBeat March 15, 2025 Share Link copied to clipboard. Remove Ads Sutro Biopharma ( NASDAQ:STRO - Get Free Report ) was downgraded by investment
    Read more...
Share on,